For example, the lower expression levels of CD138 in colorectal adenocarcinoma and in invasive urothelial carcinoma (pT2-4) as compared to colon adenomas and noninvasive bladder tumors (pTa) argues for a loss of CD138 paralleling tumor progression in these tumors. The gene discussed is SDC1; the disease is colorectal adenocarcinoma.